Providing Specialized Care for Primary Biliary Cholangitis
University of Chicago Medicine physicians collaborate closely to form a multidisciplinary team that is highly skilled in diagnosing and treating primary biliary cholangitis. Your treatment plan will be developed by specialists and designed to fit your specific needs.
What is Primary Biliary Cholangitis?
If you have primary biliary cholangitis (PBC), it means the bile ducts in your liver – a series of tubes that transport bile through your liver, small intestine and gallbladder – are damaged. Bile is an important digestive juice needed to break down fats and absorb certain vitamins. In PBC, the destroyed ducts cause a build up of bile in your liver over time. If left untreated, this can lead to permanent scarring of the liver called cirrhosis. Most patients do not have symptoms with PBC when they’re diagnosed, although some may experience itchiness, fatigue and dryness of the mouth and eyes. Eventually, some patients may also experience belly pain and yellowing of the skin, among other symptoms. Unlike primary sclerosing cholangitis, patients with PBC are not at increased risk for bile duct cancers.
Primary Biliary Cholangitis Treatment
Currently, there is no known treatment to cure primary biliary cholangitis. However, certain medications can help slow its progression, and your healthcare provider can treat you for the symptoms and complications associated with the disease. On rare occasions, people who develop serious complications from PBC may need a liver transplant.
Frequently Asked Questions about Primary Biliary Cholangitis
Symptoms of PBC can develop slowly, and many patients have no symptoms at first. The initial symptoms of PBC are:
- Itchy skin
- Belly pain
- Dry mouth and eyes
As the disease progresses, complications of cirrhosis and portal hypertension (high pressure within the blood vessels that drain into the liver) may develop. In addition, osteoporosis (thinning of the bones), fat soluble vitamin deficiency (vitamin A, D, E, K) and fat deposit-forming nodules on the eyelids (xanthelasma) or at the joints and buttocks (xanthoma) are common complications of PBC.
It’s believed that an overactive immune system causes primary biliary cholangitis, but what triggers this over-activity still isn’t clearly known. A genetic predisposition for PBC likely exists, and exposure to certain bacteria, viruses or toxins is believed to somehow trigger the immune system, which reacts in an inappropriate way and causes injury to the bile ducts. PBC affects mostly women.
Your doctor will do a complete health history and physical exam. In order to accurately diagnose primary biliary cholangitis, your doctor may use the following methods:
- Blood tests to see whether you have abnormal liver enzymes (an increase in these enzymes is due to damaged bile ducts). Your doctor will also test you for anti-mitochondrial antibodies (AMAs), which are almost always present in patients with PBC – so the diagnosis can usually be made based on blood tests alone
- Transient Elastography (Fibroscan®) is a special ultrasound that measures the amount of fat in the liver and the stiffness of the liver, which are indirect measures of the amount of scarring present.
- MR Elastography is a special way of obtaining an MRI that also measures the amount of fat in, and stiffness of, the liver.
- Liver biopsy. A small sample of liver tissue is taken and checked under a microscope. It can confirm the diagnosis of PBC and provide information on the presence and severity of scar tissue. It also allows your doctor to examine your liver for other diseases.
Although primary biliary cholangitis can’t be cured, its progression can be slowed with ursodeoxycholic acid (UCDA) and obeticholic acid, medications that can help improve the bile flow in your liver. Your health care provider can also treat your PBC symptoms; cholestyramine, colestipol hydrochloride, antihistamines, rifampin and naltrexone are all medicines that may be used to treat the itching caused by PBC.
Vitamin supplements can correct deficiencies in fat soluble vitamins that you may have. Osteoporosis is common in patients with primary biliary cholangitis, and your bone density will need to be monitored by your doctor. Cholesterol problems also tend to develop in patients with advanced stages of the disease; you may need treatment to avoid additional complications such as heart disease or stroke.
If primary biliary cholangitis eventually causes your liver to fail, your doctor may recommend a liver transplant. Liver transplants can cure primary biliary cholangitis, although PBC may recur in the new liver in a small number of patients.
Why Choose UChicago Medicine for Liver Disease Care
Our internationally renowned specialists have extensive expertise in treating common and complex liver diseases.
Coordinated, Collaborative Care
Some people with liver disease have related medical problems in other areas, such as diabetes, kidney disease or heart disease. At UChicago Medicine, all of our highly specialized physicians work under the same roof and are in continual communication with one another. Whether you need care from an endocrinologist, nephrologist, cardiologist, transplant surgeon or any other specialist, you can be assured that these specialists will collaborate on your behalf.
Personalized Approach to Care
Individually tailored treatment, personalized support and ongoing education help patients through the lengthy and often challenging journey of living with liver disease. Nurse specialists, physician assistants, social workers, registered dietitians and other members of our team have important roles supporting each patient and their family throughout treatment.
A Tradition of Excellence
Today’s UChicago Medicine physicians, researchers and members of our hepatology team build on more than eight decades of experience, discoveries and treatment innovations related to liver disease. Our team oversees many clinical trials of new therapies for liver disease.
Research & Clinical Trials
Research leads to better ways to treat, diagnose and even prevent liver disease. Members of our team are actively involved in research on two fronts: in the lab (basic research) and with patients (clinical research).
In the lab, scientists are focusing on hepatitis and other liver diseases at the cellular level. Deeper understanding about how liver disease develops and progresses can lead to more effective treatments.
Clinical research often has a more timely impact on treating liver disease. As one of the nation’s leading academic hospitals, UChicago Medicine offers many clinical trials for promising new therapies. Often, these clinical trials are open to individuals whose disease has relapsed or resisted standard treatments.
Liver Transplant Institute
The University of Chicago Medicine is one of the most experienced centers for liver transplantation. Our liver transplant program was established in 1984 — the first in the Midwest and only the fourth liver transplant program in the U.S. at that time. Over the decades, transplant surgeons here have made innovations that have revolutionized liver transplantation, particularly in the area of living-donor transplant.
Ranked Among the Nation's Best
The University of Chicago Medicine has one of the premier gastroenterology and hepatology programs in the United States. Year after year, our GI program is ranked among the nation’s best for treating digestive system disorders.